Side-by-Side Comparison · 2026

Adipotide vs CagriSema

Adipotide vs CagriSema — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

Adipotide
Metabolic & Mitochondrial

Adipotide (FTPP) is an experimental peptidomimetic that selectively targets and destroys blood vessels supplying white adipose tissue. It consists of a homing peptide that binds prohibitin on adipose vasculature, linked to a proapoptotic sequence that triggers cell death in the t...

Calculate Adipotide dose →
CagriSema
Metabolic & Mitochondrial

9%) and representing one of the strongest obesity pharmacotherapy results in clinical history. The combination works through complementary mechanisms: GLP-1 suppresses appetite centrally while amylin slows gastric emptying and promotes satiety signaling....

Calculate CagriSema dose →
Key Parameters
Parameter Adipotide CagriSema
Category Metabolic & Mitochondrial Metabolic & Mitochondrial
Research Preclinical Phase III
Half-Life - -
Typical Dose 1 mg/kg body weight Cagrilintide 2.4 mg + Semaglutide 2.4 mg
Frequency Daily (research cycles) Once weekly
Route Subcutaneous Subcutaneous (weekly)
FDA Status Not Approved Not Approved

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Frequently Asked Questions
What is the difference between Adipotide and CagriSema?
Adipotide: Adipotide (FTPP) is an experimental peptidomimetic that selectively targets and destroys blood vessels supplying white adipose tissue. It consists of a homing peptide that binds prohibitin on adipose ... CagriSema: 9%) and representing one of the strongest obesity pharmacotherapy results in clinical history. The combination works through complementary mechanisms: GLP-1 suppresses appetite centrally while amylin ...
Which has a longer half-life, Adipotide or CagriSema?
Adipotide half-life: unknown. CagriSema half-life: unknown.
Can you stack Adipotide and CagriSema?
Adipotide and CagriSema are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.